Paragraph 8 Amendment of Schedule 4 (periodic fees for licences)I1

In Schedule 4, in paragraph 1, in the definition of “limited use drug” for “which is in respect of an orphan medicinal product” substitute “ in respect of which an orphan marketing authorisation has been granted ”.